Literature DB >> 3356708

Purification of a skeletal muscle polypeptide which stimulates choline acetyltransferase activity in cultured spinal cord neurons.

J L McManaman1, F G Crawford, S S Stewart, S H Appel.   

Abstract

Extracts of rat skeletal muscle contain neurotrophic factors which stimulate the development of choline acetyltransferase in embryonic day 14 rat spinal cord cultures. The trophic activity does not bind heparin-Sepharose or lectin affinity columns. However, mild acid treatment separates the trophic activity into soluble and insoluble fractions. The acid-insoluble activity has been purified 5000-fold to apparent homogeneity using preparative sodium dodecyl sulfate gel electrophoresis to achieve final purification. The purified factor migrates as a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and isoelectric focusing, with an apparent molecular mass of 20 kDa and a pI of 4.8. The activity and apparent molecular weight of the purified factor are unaltered by treatment with reducing agents or incubation in acidic conditions. Activity, however, is destroyed by heating or protease treatment. Thus, the factor appears to be a single polypeptide without significant levels of glycosylation or charge microheterogeneity. These results represent the first purification of a neurotrophic factor from skeletal muscle. The physical properties and amino acid composition of this factor differ from those of nerve growth factor and heparin-binding growth factors, as well as from the neurotrophic factor from heart cell conditioned medium which induces cholinergic development in sympathetic neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356708

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker.

Authors:  M Hahn; S L Hahn; D M Stone; T H Joh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse.

Authors:  Jin Yu; Hong Zhu; Dorothy Ko; Mark S Kindy
Journal:  Brain Res       Date:  2008-08-29       Impact factor: 3.252

3.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 4.  Neuropeptides as growth and differentiation factors in general and VIP in particular.

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

Review 5.  The cholinergic neuronal phenotype in Alzheimer's disease.

Authors:  J K Blusztajn; B Berse
Journal:  Metab Brain Dis       Date:  2000-03       Impact factor: 3.584

6.  Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture.

Authors:  S Saadat; M Sendtner; H Rohrer
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

7.  Peripherin expression in hippocampal neurons induced by muscle soluble factor(s).

Authors:  K Djabali; A Zissopoulou; M J de Hoop; S D Georgatos; C G Dotti
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.